The Disease Forecasting Company.

Airfinity tracks, simulates and predicts population level disease outcomes in real time to inform decisions that can increase the global life span.

The world’s most trusted independent health intelligence, cited over 16,000 times in 2022

Analysis & Insights

Airfinity further expands into APAC with launch of Japan office
Airfinity further expands into APAC with launch of Japan office

After successful expansion into North America last year, Airfinity is proud to be opening a new office in Japan to provide a formal base for its activities across the APAC region.

Read More →

More from Airfinity

Airfinity launches obesity intelligence solution to forecast and simulate obesity related outcomes

Stockpiles worth $1.1 billion of COVID-19 antiviral pill Paxlovid have expired in UK and Europe

Airfinity Named The Financial Times' Healthcare Tech Champion 2023

Airfinity upgrades global biorisk platform

Airfinity named among Bloomberg’s UK Startups to Watch 2023

France faces massive increase in dengue cases by 2030

Wegovy costs $1.3m to prevent one heart attack, stroke, or cardiovascular death

View All →

In the News

The race to develop the next generation of weight-loss drugs

Financial Times | Apr 1, 2024

AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: the RAVEN cohort study

Journal of Infection | Feb 29, 2024

Redefining pandemic preparedness: Multidisciplinary insights from the CERP modelling workshop in infectious diseases, workshop report

ScienceDirect | Feb 23, 2024

England and Wales in whooping cough epidemic, experts warn

The Telegraph | Feb 16, 2024

View All →

A pioneer in predictive health intelligence


What's happening in a given disease area?

Airfinity is the most comprehensive, single source of intelligence for new developments in your chosen area.


Identify the true need for a vaccine or a treatment.

Our suite of dynamic predictive indicators help you navigate highly dynamic and uncertain market developments and see the real opportunities.


Maximise impact to save lives

Our analytics and probabilistic tools inform key decisions on resource allocation, investment and procurement decisions to maximise impact of a given drug or vaccine and ultimately improve as many lives as possible.

Analyse, simulate, and predict the changing health landscape

Airfinity develops and deploys dynamic disease forecasting models to support horizon scanning, medical countermeasure impact modelling, clinical trial site optimisation, scenario-based demand intelligence, portfolio optimisation and more.

What our users say?


“The Airfinity report is a guide for world leaders to fix a more ambitious action plan.”

Gordon Brown, WHO Ambassador for Global Health Financing & former UK Prime Minister

hm government

“Airfinity has been instrumental in our country's COVID response.”

Head of UK Government
Vaccine Task Force


In a dynamic environment, Airfinity enabled us to remain on track with daily developments to enable more accurate decision-making. Airfinity combines nimbleness of real time data and their group of scientists that can analyse, model and provide strategic analysis for critical decision making.”

Iskra Reic, Executive Vice-President


“Probably the most expansive, accurate and helpful of the multiple data sets on an international scale”

Sir John Bell ,
University of Oxford